[Editor’s Note: Deadline alert! Thursday, October 12 is the last day you can register early for the best …
Tag:
evaluating
-
-
Medicine
Ionis provides update on development program evaluating PCSK9 antisense medicine for the treatment of hypercholesterolemia
ION449 (AZD8233) met phase primary endpoint 2b Solano Studies for patients with hypercholesterolemia ION449 will not proceed to …